About

Provided by Goodwin

We understand how structural changes are disrupting the sector — and creating opportunities for companies and investors. These include trends related to reimbursement models; consolidation, development, and commercialization of new technologies; accelerating consumerism; and the ever-evolving complexities of state and federal regulations. We are also at the forefront of issues arising from the convergence of traditional healthcare with innovative technologies, including those driven by artificial intelligence, machine learning, big data, and digital therapeutics.

To fuel growth across the business lifecycle, we connect healthcare innovators with our private equity and venture capital clients. That includes everything from health systems and physician practices to dental and hospice service providers. We also have a long record of successfully defending clients in FCA qui tam litigation and fraud and abuse investigations as well as on matters involving reimbursement disputes and disclosures to proactively mitigate risks.

Chambers Review

Provided by Chambers
Healthcare: Highly Regarded - USA - Nationwide
2
Band 2
What the team is known for

Goodwin has a strong group representing a range of clients in the healthcare and life sciences sectors. The team adeptly handles transactional matters including complex acquisitions, and offers complementary expertise in litigation. The firm is also well placed to advise on regulatory issues facing the pharmaceutical industry.

Notable practitioners

DC-based Kirk Ogrosky and Roger Cohen in New York form part of the firm's nationwide healthcare practice.

Work Highlights

Provided by Goodwin
  • Goodwin provided counsel to affiliated investment funds of InTandem Capital Partners in completing its acquisition of Nebraska Orthopaedic Hospital.

Strengths

Provided by Chambers

Members

Provided by Goodwin

Chris Wilson

Head of Department

David Cappillo

Head of Department

James Gatta

Head of Department